MD

Matt De Silva

North America, California, United States, San Francisco

Description

Matt De Silva is the Chief Operating Officer at Pathos. He was the CEO at Notable Labs

Investor Profile

Matt De Silva has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Health Care
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Matt De Silva frequently co-invest with?

Two Sigma Ventures
North America, New York, United States, New York
Co-Investments: 1
Wireframe Ventures
North America, California, United States, Mill Valley
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
Builders VC
North America, California, United States, San Francisco
Co-Investments: 2
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 1
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 1
Lux Capital
North America, New York, United States, New York
Co-Investments: 1
Bioverge
North America, California, United States, San Francisco
Co-Investments: 2
Village Global
North America, California, United States, Covina
Co-Investments: 1
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does Matt De Silva often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
AZ
North America, California, United States, San Francisco
Shared Deals: 1
KM
North America, California, United States, San Francisco
Shared Deals: 1
VR
North America, California, United States, San Francisco
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 2

What are some of recent deals done by Matt De Silva?

Eigen Therapeutics

Redwood City, California, United States

Biotechnology company developing combination therapeutics for cancer

BiotechnologyLife Science
SeedDec 8, 2022
Amount Raised: $7,000,000
Arpeggio Bio

Boulder, Colorado, United States

Arpeggio builds technology to watch and learn how drugs work.

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics
Series ASep 7, 2022
Amount Raised: $17,000,000
Enveda Biosciences

Boulder, Colorado, United States

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

BiotechnologyPharmaceuticalTherapeutics
Series AJun 22, 2021
Amount Raised: $51,000,000